Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Zenas BioPharma, Inc. Common Stock, Common Stock

ZBIO

NSQ

$10.01

+$0.25

(2.56%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

3.16M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$8.33 L

$26.25 H

$10.01

About Zenas BioPharma, Inc. Common Stock, Common Stock

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts. more

Returns

Data is not properly formatted.

Time Frame	ZBIO		S&P500
1-Week Return	12.22%%	%	-3%%
1-Month Return	-19.6%%	%	-0.73%%
3-Month Return	-47.32%%	%	2.87%%
6-Month Return	-44.85%%	%	7.17%%

Financials

	Dec '22	Dec '23
Total Revenue	-	50.00M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	75.20M	77.15M	[{"date":"2022-12-31","value":97.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(75.20M)	(27.15M)	[{"date":"2022-12-31","value":-7519900000,"profit":false},{"date":"2023-12-31","value":-2714700000,"profit":false}]
Total Non-Operating Income/Expense	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	(119.28M)	(36.82M)	[{"date":"2022-12-31","value":-11928200000,"profit":false},{"date":"2023-12-31","value":-3682300000,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(119.28M)	(37.12M)	[{"date":"2022-12-31","value":-11928200000,"profit":false},{"date":"2023-12-31","value":-3712400000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(119.28M)	(37.12M)	[{"date":"2022-12-31","value":-11928200000,"profit":false},{"date":"2023-12-31","value":-3712400000,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	2.59%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	(63.90%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(69.13%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(68.88%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(68.88%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '22	Dec '23
Total Assets
Current Assets	68.44M	59.80M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.38,"profit":true}]
Non-current Assets	6.13M	8.38M	[{"date":"2022-12-31","value":73.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	74.58M	68.18M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.42,"profit":true}]

Total Liabilities
Current Liabilities	25.97M	23.26M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.57,"profit":true}]
Non-current Liabilities	240.90M	270.64M	[{"date":"2022-12-31","value":89.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	266.87M	293.90M	[{"date":"2022-12-31","value":90.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(193.28M)	(230.40M)	[{"date":"2022-12-31","value":-19327900000,"profit":false},{"date":"2023-12-31","value":-23040300000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	(192.29M)	(225.72M)	[{"date":"2022-12-31","value":-19228600000,"profit":false},{"date":"2023-12-31","value":-22572100000,"profit":false}]

Total Liabilities & Shareholders Equity	74.58M	68.18M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.42,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	(12.62%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Assets	-	36.53%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	-	(8.58%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(10.43%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Liabilities	-	12.35%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	10.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	19.21%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	17.39%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(8.58%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Sep '23	Dec '23	Mar '24	Jun '24
Total Assets
Current Assets	76.68M	59.80M	39.70M	188.60M	[{"date":"2023-09-30","value":40.66,"profit":true},{"date":"2023-12-31","value":31.71,"profit":true},{"date":"2024-03-31","value":21.05,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	7.12M	8.38M	9.35M	11.35M	[{"date":"2023-09-30","value":62.68,"profit":true},{"date":"2023-12-31","value":73.78,"profit":true},{"date":"2024-03-31","value":82.33,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Assets	83.79M	68.18M	49.05M	199.95M	[{"date":"2023-09-30","value":41.91,"profit":true},{"date":"2023-12-31","value":34.1,"profit":true},{"date":"2024-03-31","value":24.53,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	15.56M	23.26M	30.33M	39.11M	[{"date":"2023-09-30","value":39.78,"profit":true},{"date":"2023-12-31","value":59.47,"profit":true},{"date":"2024-03-31","value":77.56,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Liabilities	270.47M	270.64M	271.21M	449.63M	[{"date":"2023-09-30","value":60.15,"profit":true},{"date":"2023-12-31","value":60.19,"profit":true},{"date":"2024-03-31","value":60.32,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	286.02M	293.90M	301.55M	488.73M	[{"date":"2023-09-30","value":58.52,"profit":true},{"date":"2023-12-31","value":60.14,"profit":true},{"date":"2024-03-31","value":61.7,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	(205.82M)	(230.40M)	(258.20M)	(296.18M)	[{"date":"2023-09-30","value":-20581600000,"profit":false},{"date":"2023-12-31","value":-23040300000,"profit":false},{"date":"2024-03-31","value":-25820300000,"profit":false},{"date":"2024-06-30","value":-29618000000,"profit":false}]
Other Stockholders' Equity	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	(202.23M)	(225.72M)	(252.50M)	(288.78M)	[{"date":"2023-09-30","value":-20223200000,"profit":false},{"date":"2023-12-31","value":-22572100000,"profit":false},{"date":"2024-03-31","value":-25249500000,"profit":false},{"date":"2024-06-30","value":-28878200000,"profit":false}]

Total Liabilities & Shareholders Equity	83.79M	68.18M	49.05M	199.95M	[{"date":"2023-09-30","value":41.91,"profit":true},{"date":"2023-12-31","value":34.1,"profit":true},{"date":"2024-03-31","value":24.53,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

	Sep '23	Dec '23	Mar '24	Jun '24
Total Assets
Current Assets	-	(22.00%)	(33.61%)	375.00%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-5.87,"profit":false},{"date":"2024-03-31","value":-8.96,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	-	17.71%	11.58%	21.46%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":82.5,"profit":true},{"date":"2024-03-31","value":53.95,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Assets	-	(18.63%)	(28.06%)	307.64%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-6.06,"profit":false},{"date":"2024-03-31","value":-9.12,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	49.50%	30.42%	28.93%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":61.45,"profit":true},{"date":"2024-06-30","value":58.44,"profit":true}]
Non-current Liabilities	-	0.07%	0.21%	65.78%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":0.1,"profit":true},{"date":"2024-03-31","value":0.32,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	-	2.75%	2.60%	62.08%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":4.44,"profit":true},{"date":"2024-03-31","value":4.19,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	-	11.95%	12.07%	14.71%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":81.22,"profit":true},{"date":"2024-03-31","value":82.03,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	11.61%	11.86%	14.37%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":80.82,"profit":true},{"date":"2024-03-31","value":82.54,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(18.63%)	(28.06%)	307.64%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-6.06,"profit":false},{"date":"2024-03-31","value":-9.12,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(65.65M)	(30.53M)	[{"date":"2022-12-31","value":-6565200000,"profit":false},{"date":"2023-12-31","value":-3052900000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	59.39M	20.12M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":33.87,"profit":true}]

Net Change in Cash	(8.50M)	(10.35M)	[{"date":"2022-12-31","value":-850000000,"profit":false},{"date":"2023-12-31","value":-1035200000,"profit":false}]

Free Cash Flow
Free Cash Flow	(67.85M)	(30.55M)	[{"date":"2022-12-31","value":-6785000000,"profit":false},{"date":"2023-12-31","value":-3054600000,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	(53.50%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(66.13%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	21.79%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(54.98%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Jun '23	Sep '23	Dec '23	Mar '24	Jun '24	TREND
Operating Activities
Net Operating Cash Flow	(20.91M)	31.85M	(15.40M)	(19.10M)	(30.96M)	[{"date":"2023-06-30","value":-65.67,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-48.36,"profit":false},{"date":"2024-03-31","value":-59.98,"profit":false},{"date":"2024-06-30","value":-97.21,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	11.00K	20.00M	50.00K	(614.00K)	177.74M	[{"date":"2023-06-30","value":0.01,"profit":true},{"date":"2023-09-30","value":11.25,"profit":true},{"date":"2023-12-31","value":0.03,"profit":true},{"date":"2024-03-31","value":-0.35,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]

Net Change in Cash	(20.73M)	51.85M	(15.45M)	(19.70M)	146.78M	[{"date":"2023-06-30","value":-14.13,"profit":false},{"date":"2023-09-30","value":35.33,"profit":true},{"date":"2023-12-31","value":-10.53,"profit":false},{"date":"2024-03-31","value":-13.42,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(20.91M)	31.85M	(15.40M)	(19.12M)	(30.99M)	[{"date":"2023-06-30","value":-65.67,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-48.36,"profit":false},{"date":"2024-03-31","value":-60.05,"profit":false},{"date":"2024-06-30","value":-97.32,"profit":false}]

	Jun '23	Sep '23	Dec '23	Mar '24	Jun '24	TREND
Operating Activities
Net Operating Cash Flow	-	(252.29%)	(148.36%)	24.04%	62.07%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":-406.44,"profit":false},{"date":"2023-12-31","value":-239.01,"profit":false},{"date":"2024-03-31","value":38.73,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	181718.18%	(99.75%)	(1328.00%)	(29047.72%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-0.05,"profit":false},{"date":"2024-03-31","value":-0.73,"profit":false},{"date":"2024-06-30","value":-15.99,"profit":false}]

Net Change in Cash	-	(350.06%)	(129.81%)	27.49%	(844.99%)	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":-1273.5,"profit":false},{"date":"2023-12-31","value":-472.22,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":-3074.01,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(252.29%)	(148.36%)	24.18%	62.07%	[{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":-406.46,"profit":false},{"date":"2023-12-31","value":-239.02,"profit":false},{"date":"2024-03-31","value":38.96,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	ZBIO
Current Ratio	4.82

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ZBIO
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	ZBIO
Debt Ratio Lower is generally better. Negative is bad.	2.44
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-1.44

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ZBIO
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Zenas BioPharma, Inc. Common Stock share price today?

Zenas BioPharma, Inc. Common Stock (ZBIO) share price today is $10.01

Can Indians buy Zenas BioPharma, Inc. Common Stock shares?

Yes, Indians can buy shares of Zenas BioPharma, Inc. Common Stock (ZBIO) on Vested. To buy Zenas BioPharma, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ZBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Zenas BioPharma, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Zenas BioPharma, Inc. Common Stock (ZBIO) via the Vested app. You can start investing in Zenas BioPharma, Inc. Common Stock (ZBIO) with a minimum investment of $1.

How to invest in Zenas BioPharma, Inc. Common Stock shares from India?

You can invest in shares of Zenas BioPharma, Inc. Common Stock (ZBIO) via Vested in three simple steps:

Click on Sign Up or Invest in ZBIO stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Zenas BioPharma, Inc. Common Stock shares

What is Zenas BioPharma, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Zenas BioPharma, Inc. Common Stock (ZBIO) is $26.25. The 52-week low price of Zenas BioPharma, Inc. Common Stock (ZBIO) is $8.33.

What is Zenas BioPharma, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Zenas BioPharma, Inc. Common Stock (ZBIO) is

What is Zenas BioPharma, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Zenas BioPharma, Inc. Common Stock (ZBIO) is 0.00

What is Zenas BioPharma, Inc. Common Stock dividend yield?

The dividend yield of Zenas BioPharma, Inc. Common Stock (ZBIO) is 0.00%

What is the Market Cap of Zenas BioPharma, Inc. Common Stock?

The market capitalization of Zenas BioPharma, Inc. Common Stock (ZBIO) is

What is Zenas BioPharma, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Zenas BioPharma, Inc. Common Stock is ZBIO